2019 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: Induction Therapy

Date: Tuesday, June 4, 2019

Time: 4:30pm-6:00pm

Location: Room 304

Session Type: Concurrent Session

Meeting: 2019 American Transplant Congress

4:30pm-4:42pm: Effect of Induction Therapy on Outcomes of De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from the TRANSFORM Study

R. Oberbauer¹, F. Vincenti¹, O. Viklicky¹, U. Huynh-Do¹, D. Kim¹, J. M. Cruzado¹, Y. Qazi¹, M. S. Kim¹, P. Narvekar², M. P. Hernandez Gutierrez², P. Bernhardt², D. Kuypers¹

4:42pm-4:54pm: Effect of ATG on Monocytic Myeloid-Derived Suppressor Cells and Its Associated Mechanisms in Kidney Transplantation Recipients

Y. Jiang, X. Zhang

4:54pm-5:06pm: To Each Their Own: Center-Level Variation in Tailoring Induction Immunosuppression to Kidney Transplant Recipients

S. Bae, A. Massie, J. Garonzik Wang, M. McAdams DeMarco, J. Coresh, D. Segev

5:06pm-5:18pm: Association Of Lymphocyte-depleting Antibody And Steroids Induction With The Risk And Outcomes Of Post-transplant Diabetes: Analysis Of Deceased-donor Kidney Transplants

A. Santos¹, J. Gregg², U. L. Akanit³, K. Alquadan¹, H. Bejjanki¹, K. L. Womer¹

5:18pm-5:30pm: Basiliximab versus T-cell Depleting Induction Therapy in Elderly Kidney Transplant Recipients

G. Vranic, H. Shah, B. Thomas, B. Javaid, J. Moore, M. Cooper, A. Gilbert

5:30pm-5:42pm: Age-Related Effects on Thymic Output and Homeostatic T Cell Expansion Following Depletional Induction

H. Xu, H. Lee, A. Kirk

5:42pm-5:54pm: Is Alemtuzumab Induction Safe In Septuagenarians Undergoing Deceased Donor Kidney Transplantation?

D. Harriman, V. Gurram, C. Jay, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, A. Mena-Gutierrez, R. Stratta

« View all sessions from the 2019 American Transplant Congress